Annexon Biosciences Alternatives & Competitors

8 companies similar to Annexon Biosciences — Unlocking the Next Generation of Complement Therapies

Montis Biosciences

Pioneering next-gen therapeutics to harness C1q's central role in neuroinflammatory diseas...

14 $9.06M

Belgium

Biotechnology Health and Wellness

Compare

VeonGen Therapeutics GmbH

Dedicated to develop the medicines of the future

9 Series A

Planegg, Germany

Biotechnology Health Care +1

Compare

Concert Pharmaceuticals, Inc.

Creating New Possibilities for Patients to Live Their Lives

38 Post-IPO Equity $155.70M

Lexington, United States

Biotechnology Health Care +1

Ocuphire Pharma

Restoring Vision and Clarity

15 Post-IPO Equity $24.56M

Farmington Hills, United...

Biopharma Biotechnology +1

Rival Readout

Competing with Annexon Biosciences? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Precigen

Precigen (Nasdaq: PGEN) is a biopharmaceutical company advancing the next generation of ge...

152 Post-IPO Equity $547.90M

Germantown, United States

Biotechnology Health and Wellness +1

ESCAPE Bio

A CLINICAL-STAGE COMPANY DEVELOPING NOVEL, PRECISELY TARGETED THERAPIES FOR GENETIC NEUROD...

6 Series B $187.08M

South San Francisco, Unit...

Biotechnology Health Care

ASIT-biotech

1 Post-IPO Debt $12.00M

Angleur, Belgium

Biotechnology Health Care

AusperBio

Transforming Patient Lives For a Better Tomorrow

8 Series B $252.66M

San Mateo, United States

Biopharma Biotechnology +1

About Annexon Biosciences

Annexon Biosciences is a clinical-stage biopharmaceutical company founded in 2011, with a focus on developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye. The company's pipeline consists of innova...

Business keywords

Biopharmaceutical, Complement Therapies, Clinical-stage, Autoimmune Disorders, Neurodegenerative Disorders, Ophthalmic Disorders, Pipeline, Platform Technology, C1q, Classical Complement Pathway, Product Candidates, Biomarker-driven Strategy, Intravenous Administration, Intravitreal Administration, Subcutaneous Administration

Frequently Asked Questions

Companies similar to Annexon Biosciences include Montis Biosciences, VeonGen Therapeutics GmbH, Concert Pharmaceuticals, Inc., Ocuphire Pharma, Precigen. They work in Biotechnology and Health Care and share Annexon Biosciences's focus on biopharmaceutical, autoimmune disorders and intravitreal administration.

Bounce Watch lists 8 companies that share Annexon Biosciences's industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Annexon Biosciences: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Annexon Biosciences Profile Montis Biosciences Alternatives VeonGen Therapeutics GmbH Alternatives Concert Pharmaceuticals, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Annexon Biosciences on 9 Jun 2026. The 8 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.